Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Actavis

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs.

Actavis

FDA approves two new IBS medicines

FDA approves two new IBS medicines The FDA has approved two new treatments for irritable bowel syndrome with diarrhoea (IBS-D) in the form of Actavis' Viberzi (eluxadoline) and Salix' Xifaxan (rifaximin). . ... At Actavis, we are dedicated to providing new treatment options, and the

Endo buys Par for $8bn as M&A mania marches on

Endo buys Par for $8bn as M&A mania marches on Meanwhile, generic manufacturer Actavis completed its $66bn acquisition of specialty drugmaker Allergan in March.

Get Real! The Rise of Observational Data In Healthcare

Get Real! The Rise of Observational Data In Healthcare Furthermore, Marco Taglietti, chief medical officer of Forest Laboratories (now part of Actavis), said last year that the company has started to routinely carry out health economic studies along with the

Pharma deals in March 2015

Pharma deals in March 2015 Another example this month is Actavis who plan to divest to Amneal its generic products in Australia whilst retaining the branded products.

Heart drug sales continue downward spiral

Heart drug sales continue downward spiral The drug was making more than $2.4bn at its peak but in 2014 its sales were hit by generic competition after Actavis gained US approval for its telmisartan copy. .

[ Previous 5 results ] 7 8 9 10 11 12 13 14 15 16 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...
Behaviour change through medical education: How can we turn aspiration into reality?
Practical, evidence-based insights into a CME process that aims to effect measurable behaviour change...

Infographics